Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.910
-0.030 (-3.19%)
Nov 21, 2024, 4:00 PM EST - Market closed
Silo Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 4.86 | 3.52 | 11.37 | 9.84 | 1.13 | 0.11 | Upgrade
|
| Short-Term Investments | 3.15 | 4.14 | 0 | 0.42 | 0 | 0.01 | Upgrade
|
| Cash & Short-Term Investments | 8.02 | 7.67 | 11.37 | 10.26 | 1.13 | 0.12 | Upgrade
|
| Cash Growth | -8.62% | -32.58% | 10.85% | 808.83% | 831.59% | -78.56% | Upgrade
|
| Accounts Receivable | - | 0 | 0 | 0 | - | - | Upgrade
|
| Receivables | - | 0 | 0.07 | 0 | 0.02 | 0.2 | Upgrade
|
| Inventory | - | - | - | - | - | 0.16 | Upgrade
|
| Prepaid Expenses | 0.25 | 0.01 | 0.12 | 0.06 | 0.13 | 0.02 | Upgrade
|
| Other Current Assets | - | 0.01 | 0.02 | 0.08 | 0.14 | - | Upgrade
|
| Total Current Assets | 8.26 | 7.68 | 11.57 | 10.4 | 1.43 | 0.49 | Upgrade
|
| Other Intangible Assets | 0.24 | - | - | - | - | - | Upgrade
|
| Long-Term Accounts Receivable | - | 0.01 | 0.01 | 0.01 | - | - | Upgrade
|
| Long-Term Deferred Charges | - | 0.02 | 0.06 | 0.02 | - | - | Upgrade
|
| Other Long-Term Assets | 0.06 | 0.04 | - | - | - | - | Upgrade
|
| Total Assets | 8.57 | 7.75 | 11.64 | 10.49 | 1.43 | 0.49 | Upgrade
|
| Accounts Payable | 0.97 | 0.7 | 0.22 | 0.42 | 0.13 | 0.05 | Upgrade
|
| Accrued Expenses | - | - | 0.14 | - | - | - | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.06 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.01 | - | Upgrade
|
| Current Unearned Revenue | 0.07 | 0.07 | 0.07 | 0.07 | - | - | Upgrade
|
| Total Current Liabilities | 1.04 | 0.78 | 0.44 | 0.49 | 0.14 | 0.12 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0 | - | Upgrade
|
| Long-Term Unearned Revenue | 0.74 | 0.79 | 0.87 | 0.94 | - | - | Upgrade
|
| Total Liabilities | 1.78 | 1.57 | 1.3 | 1.43 | 0.15 | 0.12 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 20.3 | 17.53 | 17.51 | 12.32 | 7.03 | 2.63 | Upgrade
|
| Retained Earnings | -13.53 | -10.87 | -7.17 | -3.26 | -5.76 | -2.66 | Upgrade
|
| Treasury Stock | -0.01 | -0.47 | - | - | - | - | Upgrade
|
| Comprehensive Income & Other | 0.02 | -0.01 | - | - | - | - | Upgrade
|
| Total Common Equity | 6.78 | 6.18 | 10.34 | 9.06 | 1.28 | -0.02 | Upgrade
|
| Shareholders' Equity | 6.78 | 6.18 | 10.34 | 9.06 | 1.28 | 0.38 | Upgrade
|
| Total Liabilities & Equity | 8.57 | 7.75 | 11.64 | 10.49 | 1.43 | 0.49 | Upgrade
|
| Total Debt | - | - | - | - | 0.02 | 0.06 | Upgrade
|
| Net Cash (Debt) | 8.02 | 7.67 | 11.37 | 10.26 | 1.11 | 0.06 | Upgrade
|
| Net Cash Growth | -8.62% | -32.58% | 10.85% | 824.31% | 1772.23% | -89.08% | Upgrade
|
| Net Cash Per Share | 2.44 | 2.49 | 4.98 | 5.35 | 0.84 | 0.13 | Upgrade
|
| Filing Date Shares Outstanding | 4.48 | 2.84 | 3.16 | 1.97 | 1.7 | 0.47 | Upgrade
|
| Total Common Shares Outstanding | 4.48 | 2.91 | 3.16 | 1.97 | 1.7 | 0.47 | Upgrade
|
| Working Capital | 7.22 | 6.91 | 11.14 | 9.91 | 1.28 | 0.38 | Upgrade
|
| Book Value Per Share | 1.51 | 2.13 | 3.27 | 4.59 | 0.75 | -0.05 | Upgrade
|
| Tangible Book Value | 6.54 | 6.18 | 10.34 | 9.06 | 1.28 | -0.02 | Upgrade
|
| Tangible Book Value Per Share | 1.46 | 2.13 | 3.27 | 4.59 | 0.75 | -0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.